Cargando…
Gene therapy for ALS: A review
Amyotrophic lateral sclerosis (ALS) has historically posed unique challenges for gene-therapy-based approaches, due to a paucity of therapeutic targets as well as the difficulty of accessing both the brain and spinal cord. Recent advances in our understanding of disease mechanism and ALS genetics, h...
Autores principales: | Amado, Defne A., Davidson, Beverly L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636154/ https://www.ncbi.nlm.nih.gov/pubmed/33839324 http://dx.doi.org/10.1016/j.ymthe.2021.04.008 |
Ejemplares similares
-
CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene
por: Yrigollen, Carolyn M., et al.
Publicado: (2019) -
Next-generation strategies for gene-targeted therapies of central nervous system disorders: A workshop summary
por: Morris, Jill A., et al.
Publicado: (2021) -
Gene Therapy for ALS—A Perspective
por: Cappella, Marisa, et al.
Publicado: (2019) -
Overcoming Limitations Inherent in Sulfamidase to Improve Mucopolysaccharidosis IIIA Gene Therapy
por: Chen, Yonghong, et al.
Publicado: (2018) -
Gene Therapy in ALS and SMA: Advances, Challenges and Perspectives
por: Lejman, Jan, et al.
Publicado: (2023)